My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2015/1799 of 5 October 2015 concerning the classification of certain goods in the Combined Nomenclature

Commission Implementing Regulation (EU) 2015/1799 of 5 October 2015 concerning the classification of certain goods in the Combined Nomenclature

Implementing Regulation (EU) 2015/1799 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The goods described in column (1) of the table set out in the Annex shall be classified within the Combined Nomenclature under the CN code indicated in column (2) of that table.

Article 2

Open ↗

Binding tariff information which does not conform to this Regulation may continue to be invoked in accordance with Article 12(6) of Regulation (EEC) No 2913/92 for a period of three months from the date of entry into force of this Regulation.

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Description of goods Classification (CN Code) Reasons (1) (2) (3) A product in the form of powder, put up for retail sale in a plastic box containing 300 g. The recommended daily dose (10 g) consists of (in milligrams): — amino-acids (blend of arginine and citrulline) 5 200 — vitamin C (as ascorbic acid) 500 — L-taurine 300 — vitamin E (as D-alpha-tocopheryl acetate) 90 — alpha-lipoic acid 10 — folic acid 0,4 — lemon balm 50 — calcium (as CaCO 3 ) 66 The product also contains small amounts of citric acid, sucralose and silicon dioxide. According to the label, the product is a dietary supplement for human consumption which provides help in taking care of the body and offering a lifetime of well-being. The recommended daily dose indicated is 10 g (2 scoops). 2106 90 92 Classification is determined by general rules 1 and 6 for the interpretation of the Combined Nomenclature, Additional Note 1(a) to Chapter 30 and the wording of CN codes 2106 , 2106 90 and 2106 90 92 . The product is a preparation presented as a dietary supplement for human consumption, containing vitamins and amino-acids. The product is not intended to diagnose, treat, cure or prevent any disease within the meaning of heading 3004 . Even if it contains a level of vitamins C and E significantly higher than the recommended daily allowance, it does not meet the requirements of Additional note 1 (a) to Chapter 30. Classification under CN code 3004 is therefore excluded. As the product is put up in packaging with the indication that it maintains general health or well–being, it is a food preparation not elsewhere specified or included (see also the Harmonized System Explanatory Notes to heading 2106 , second paragraph, point (16). The product is therefore to be classified under CN code 2106 90 92 as other food preparation.

Other acts of the same type
Commission Implementing Regulation (EU) 2024/842 of 11 March 2024 re-imposing safeguard measures with regard to imports of Indica rice originating in Cambodia and Myanmar/BurmaCommission Delegated Regulation (EU) 2024/1366 of 11 March 2024 supplementing Regulation (EU) 2019/943 of the European Parliament and of the Council by establishing a network code on sector-specific rules for cybersecurity aspects of cross-border electricity flowsCommission Delegated Regulation (EU) 2024/1388 of 11 March 2024 correcting Delegated Regulation (EU) 2023/2623 supplementing Regulation (EU) 2019/472 of the European Parliament and of the Council by specifying details of the landing obligation for certain fisheries in Western Waters for the period 2024-2027Commission Delegated Regulation (EU) 2024/1701 of 11 March 2024 amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human useCommission Delegated Regulation (EU) 2024/1702 of 11 March 2024 amending Delegated Regulation (EU) No 1003/2013 as regards harmonisation of certain aspects of fees charged by the European Securities and Markets Authority to trade repositoriesCommission Delegated Regulation (EU) 2024/1703 of 11 March 2024 amending Delegated Regulation (EU) 2020/1732 as regards harmonisation of certain aspects of fees charged by the European Securities and Markets Authority to securitisation repositoriesCommission Delegated Regulation (EU) 2024/1704 of 11 March 2024 amending Delegated Regulation (EU) 2019/360 as regards harmonisation of certain aspects of fees charged by the European Securities and Markets Authority to trade repositoriesCommission Delegated Regulation (EU) 2024/1705 of 11 March 2024 amending Delegated Regulation (EU) 2022/805 as regards harmonisation of certain aspects of fees charged by the European Securities and Markets Authority to certain benchmark administratorsCommission Delegated Regulation (EU) 2024/1706 of 11 March 2024 amending Delegated Regulation (EU) No 272/2012 as regards harmonisation of certain aspects of fees charged by the European Securities and Markets Authority to credit rating agenciesCommission Delegated Regulation (EU) 2024/1765 of 11 March 2024 supplementing Regulation (EU) 2020/741 of the European Parliament and of the Council with regard to technical specifications of the key elements of risk managementCommission Implementing Regulation (EU) 2024/819 of 8 March 2024 imposing a definitive anti-dumping duty on imports of certain corrosion resistant steels originating in the People’s Republic of China following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next